دورية أكاديمية
Systemic Tranexamic Acid for Reduced Postoperative Blood Loss and Less Bleeding Complications in Fleur-de-lis Abdominoplasty and Apronectomy.
| العنوان: | Systemic Tranexamic Acid for Reduced Postoperative Blood Loss and Less Bleeding Complications in Fleur-de-lis Abdominoplasty and Apronectomy. |
|---|---|
| المؤلفون: | Wachtel C; Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Wilhelm-Epstein-Straße 4, 60431, Frankfurt am Main, Germany. carolin.wachtel@gmx.de., Rothenberger J; Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Wilhelm-Epstein-Straße 4, 60431, Frankfurt am Main, Germany.; Department of Plastic, Reconstructive and Aesthetic Surgery, Diakonie Hospital, Bad Kreuznach, Germany., Ederer IA; Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Wilhelm-Epstein-Straße 4, 60431, Frankfurt am Main, Germany., Souquet J; Department of Anesthesiology und Pain Medicine, Agaplesion Markus Hospital, Frankfurt am Main, Germany., Rieger U; Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Wilhelm-Epstein-Straße 4, 60431, Frankfurt am Main, Germany. |
| المصدر: | Aesthetic plastic surgery [Aesthetic Plast Surg] 2024 Jul; Vol. 48 (13), pp. 2465-2474. Date of Electronic Publication: 2024 Mar 28. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer-Verlag Country of Publication: United States NLM ID: 7701756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5241 (Electronic) Linking ISSN: 0364216X NLM ISO Abbreviation: Aesthetic Plast Surg Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, Springer-Verlag. |
| مواضيع طبية MeSH: | Tranexamic Acid*/administration & dosage , Tranexamic Acid*/therapeutic use , Abdominoplasty*/adverse effects , Abdominoplasty*/methods , Antifibrinolytic Agents*/administration & dosage , Antifibrinolytic Agents*/therapeutic use , Postoperative Hemorrhage*/prevention & control , Postoperative Hemorrhage*/etiology, Humans ; Female ; Retrospective Studies ; Middle Aged ; Male ; Adult ; Treatment Outcome ; Cohort Studies ; Risk Assessment ; Length of Stay/statistics & numerical data ; Blood Loss, Surgical/prevention & control |
| مستخلص: | Background: Strategies minimizing surgical bleeding, including the antifibrinolytic agent tranexamic acid, play a crucial role in clinical practice to optimize overall surgical outcomes. Despite its proven efficacy in various clinical fields, there is a limited understanding regarding the use of tranexamic acid in plastic and aesthetic procedures. This study is the first investigating the effects of systemically administered tranexamic acid on postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies. Methods: Patients who received 1 g tranexamic acid (n = 44) during fleur-de-lis abdominoplasty or apronectomy were retrospectively compared with those who did not (n = 44). In this context, the outcome parameters 24-h and total drain fluid production, drain time, hospital stay, absolute and relative drop in hemoglobin and hematocrit level as well as bleeding complications such as blood transfusion, hematoma puncture and evacuation were evaluated. Results: Tranexamic acid significantly decreased both drainage volume in 24 h (40.5%, p = 0.0046) and total drain fluid production (42.5%, p = 0.0017). Moreover, a shorter drainage time (19.4%, p = 0.0028) and hospital stay (21.4%, p = 0.0009) were observed. The administration of tranexamic acid was also associated with a reduced postoperative decline in hemoglobin and hematocrit levels. Notably, no bleeding complications were observed in patients who received tranexamic acid, while 6 events occurred in patients without (p = 0.0262). Conclusion: Systemic administration of tranexamic acid effectively reduced postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies. Level of Evidence Iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 . (© 2024. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.) |
| References: | Shander A (2007) Financial and clinical outcomes associated with surgical bleeding complications. Surgery. https://doi.org/10.1016/j.surg.2007.06.025. (PMID: 10.1016/j.surg.2007.06.02518019945) Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds M, Rupnow MF, Hammond J (2011) Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 11:135. (PMID: 10.1186/1472-6963-11-135216277883126703) Gabay M (2006) Absorbable hemostatic agents. Am J Health Syst Pharm 63:1244–1253. (PMID: 10.2146/ajhp06000316790576) Porte RJ, Leebeek FW (2002) Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62(15):2193–2211. (PMID: 10.2165/00003495-200262150-0000312381219) Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012) Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. https://doi.org/10.1136/bmj.e3054. (PMID: 10.1136/bmj.e3054226111643356857) Zhang Y, Bai Y, Chen M, Zhou Y, Yu X, Zhou H, Chen G (2019) The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials. BMC Anesthesiol 19(1):104. (PMID: 10.1186/s12871-019-0761-3311959876567423) Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ (2018) The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis. J Arthroplasty 33(10):3083–3089. (PMID: 10.1016/j.arth.2018.06.02330007789) Franchini M, Mengoli C, Cruciani M, Bergamini V, Presti F, Marano G, Pupella S, Vaglio S, Masiello F, Veropalumbo E, Piccinini V, Pati I, Liumbruno GM (2018) Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus 16(4):329–337. (PMID: 297571326034773) McCormack PL (2012) Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 72(5):585–617. (PMID: 10.2165/11209070-000000000-0000022397329) Fachinfo - Service (2023) Prescribing information, Cyklokapron®-Injektionslösung, as of November 2023, https://www.fachinfo.de. Pilbrant A, Schannong M, Vessman J (1981) Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 20(1):65–72. (PMID: 10.1007/BF005546697308275) Murao S, Nakata H, Roberts I, Yamakawa K (2021) Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis. Crit Care 25(1):380. (PMID: 10.1186/s13054-021-03799-9347249648561958) Franchini M, Mengoli C, Marietta M, Marano G, Vaglio S, Pupella S, Mannucci PM, Liumbruno GM (2018) Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus 16(1):36–43. (PMID: 293376655770313) Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network (2017) Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376(2):136–148. (PMID: 10.1056/NEJMoa160642427774838) Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF (2011) Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 114(4):862–871. (PMID: 10.1097/ALN.0b013e318210fd8f21364458) Kurnik NM, Pflibsen LR, Bristol RE, Singh DJ (2017) Tranexamic acid reduces blood loss in craniosynostosis surgery. J Craniofac Surg 28(5):1325–1329. (PMID: 10.1097/SCS.000000000000373128582303) Murphy GR, Glass GE, Jain A (2016) The efficacy and safety of tranexamic acid in cranio-maxillofacial and plastic surgery. J Craniofac Surg 27(2):374–379. (PMID: 10.1097/SCS.000000000000225026967076) Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M (2010) High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 110(2):350–353. (PMID: 10.1213/ANE.0b013e3181c92b2319996135) Sharma V, Katznelson R, Jerath A, Garrido-Olivares L, Carroll J, Rao V, Wasowicz M, Djaiani G (2014) The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia 69(2):124–130. (PMID: 10.1111/anae.1251624588023) Lecker I, Wang DS, Whissell PD, Avramescu S, Mazer CD, Orser BA (2016) Tranexamic acid-associated seizures: causes and treatment. Ann Neurol 79(1):18–26. (PMID: 10.1002/ana.2455826580862) Sigaut S, Tremey B, Ouattara A, Couturier R, Taberlet C, Grassin-Delyle S, Dreyfus JF, Schlumberger S, Fischler M (2014) Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 120(3):590–600. (PMID: 10.1097/ALN.0b013e3182a443e823903022) Guo J, Gao X, Ma Y, Lv H, Hu W, Zhang S, Ji H, Wang G, Shi J (2019) Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiol 19(1):129. (PMID: 10.1186/s12871-019-0772-0313073816631782) Elena Scarafoni E (2021) A systematic review of tranexamic acid in plastic surgery: what’s new? Plast Reconstr Surg Glob Open. https://doi.org/10.1097/GOX.00000000000. (PMID: 10.1097/GOX.00000000000339076538062149) Xu JW, Qiang H, Li TL, Wang Y, Wei XX, Li F (2021) Efficacy of topical vs intravenous tranexamic acid in reducing blood loss and promoting wound healing in bone surgery: a systematic review and meta-analysis. World J Clin Cases 9(17):4210–4220. (PMID: 10.12998/wjcc.v9.i17.4210341417838173404) Zhang P, Liang Y, Chen P, Fang Y, He J, Wang J (2016) Intravenous versus topical tranexamic acid in primary total hip replacement: a meta-analysis. Medicine. https://doi.org/10.1097/MD.0000000000005573. (PMID: 10.1097/MD.0000000000005573280332985207594) Dai WL, Zhou AG, Zhang H, Zhang J (2018) Most effective regimen of tranexamic acid for reducing bleeding and transfusions in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. J Knee Surg 31(7):654–663. (PMID: 10.1055/s-0037-160637628895645) Wheeler DR, Bucci F, Vaccari S, Di Giuli R, Vinci V, Klinger M (2023) Topical tranexamic acid: risks, benefits and novel complications in aesthetic plastic surgery. Aesthetic Plast Surg. https://doi.org/10.1007/s00266-023-03346-7. (PMID: 10.1007/s00266-023-03346-737069351) Sagiv O, Rosenfeld E, Kalderon E, Barazani TB, Zloto O, Martinowitz U, Ben Simon GJ, Zilinsky I (2018) Subcutaneous tranexamic acid in upper eyelid blepharoplasty: a prospective randomized pilot study. Can J Ophthalmol 53(6):600–604. (PMID: 10.1016/j.jcjo.2018.01.00630502984) Kochuba AL, Coombs DM, Kwiecien GJ, Sinclair NR, Zins JE (2021) Prospective study assessing the effect of local infiltration of tranexamic acid on facelift bleeding. Aesthet Surg J 41(4):391–397. (PMID: 10.1093/asj/sjaa19832644111) Parmeshwar N, Mehta SR, Piper M (2023) Reviewing the impact of topical and intravenous tranexamic acid use in breast plastic surgery. Ann Plast Surg 91(5):622–628. (PMID: 10.1097/SAP.000000000000363537405863) Ausen K, Fossmark R, Spigset O, Pleym H (2022) Safety and efficacy of local tranexamic acid for the prevention of surgical bleeding in soft-tissue surgery: a review of the literature and recommendations for plastic surgery. Plast Reconstr Surg 149(3):774–787. (PMID: 10.1097/PRS.0000000000008884351967018860217) Weissler JM, Kuruoglu D, Salinas C, Tran NV, Nguyen MT, Martinez-Jorge J, Bite U, Harless CA, Vijayasekaran A, Sharaf B (2022) Defining the role for topically administered tranexamic acid in panniculectomy surgery. Aesthet Surg J Open Forum. https://doi.org/10.1093/asjof/ojac033. (PMID: 10.1093/asjof/ojac033356924879174740) Bayter-Marín JE, Hoyos A, Cárdenas-Camarena L, Peña-Pinzón W, Bayter-Torres AF, Díaz-Díaz CA, McCormick-Méndez M, Plata-Rueda EL, Niño-Carreño CS (2023) Effectiveness of tranexamic acid in the postoperative period in body contour surgery: randomized clinical trial. Plast Reconstr Surg Glob Open. https://doi.org/10.1097/GOX.0000000000005403. (PMID: 10.1097/GOX.00000000000054033802564510653580) |
| فهرسة مساهمة: | Keywords: Apronectomy; Bleeding complications; Fleur-de-lis abdominoplasty; Postoperative blood loss; Surgical outcome; Tranexamic acid |
| المشرفين على المادة: | 6T84R30KC1 (Tranexamic Acid) 0 (Antifibrinolytic Agents) |
| تواريخ الأحداث: | Date Created: 20240329 Date Completed: 20240712 Latest Revision: 20240712 |
| رمز التحديث: | 20240712 |
| DOI: | 10.1007/s00266-024-03992-5 |
| PMID: | 38548959 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1432-5241 |
|---|---|
| DOI: | 10.1007/s00266-024-03992-5 |